PROCEPT BioRobotics Balance Sheet
NASDAQ: PRCTHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
PROCEPT BioRobotics financial position
At the end of fiscal 2025, PROCEPT BioRobotics reported total assets of $508.1 million, down 4.9% from a year earlier against total liabilities of $142.2 million. Shareholders' equity stood at $365.9 million, or 72.0% of assets. The company held $286.5 million in cash and equivalents against $51.6 million of debt, a net cash position of $234.9 million.
The current ratio (current assets divided by current liabilities) was 6.85, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.14.
Summary generated from market data by MetaCap's automated system. Methodology
PROCEPT BioRobotics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 286.50M | 333.73M | 257.22M | 221.86M | 304.32M | 100.13M |
| Receivables | 83.53M | 83.50M | 48.38M | 15.27M | 4.46M | 1.55M |
| Inventory | 70.69M | 56.17M | 39.76M | 28.54M | 13.15M | 6.92M |
| Total Current Assets | 450.38M | 481.84M | 350.57M | 272.63M | 326.17M | 110.26M |
| Property, Plant & Equipment | 30.40M | 26.71M | 28.75M | 8.66M | 5.04M | 8.27M |
| Total Assets | 508.08M | 534.02M | 404.72M | 309.33M | 337.02M | 125.97M |
| Accounts Payable | 17.29M | 10.03M | 13.50M | 9.39M | 2.03M | 1.24M |
| Short-Term Debt | — | — | — | — | 0 | 4.55M |
| Total Current Liabilities | 65.80M | 53.13M | 45.93M | 35.29M | 16.24M | 14.53M |
| Long-Term Debt | 51.62M | 51.47M | 51.34M | 51.21M | 50.00M | 44.41M |
| Total Liabilities | 142.21M | 131.80M | 123.97M | 112.26M | 69.93M | 65.01M |
| Shareholders' Equity | 365.87M | 402.22M | 280.75M | 197.07M | 267.09M | -182.89M |
| Retained Earnings | -641.56M | -545.99M | -454.57M | -348.68M | -261.52M | -201.67M |
| Total Debt | 51.62M | 51.47M | 51.34M | 51.21M | 50.00M | 48.96M |
| Net Cash (Debt) | 234.89M | 282.25M | 205.88M | 170.65M | 254.32M | 51.17M |
| Shares Outstanding | 56.32M | 54.72M | 50.77M | 44.83M | 43.68M | 4.71M |
This table shows 6 annual periods of PROCEPT BioRobotics's balance sheet, from FY 2025 back to FY 2020, across 16 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow PRCT's reporting calendar. What is a balance sheet?